CONDITIONS WE RESEARCH
As a dynamic independently held clinical research site company, The ERG research areas offers a deep bench of specialized expertise in more than 50 specific indications, with unparalleled capabilities in CNS studies.
HEALTHY VOLUNTEER
Phase I studies help researchers determine how a drug works, by understanding its clinical pharmacology. Having conducted over 2000 Phase I studies, ERG is known throughout the industry for excelling in these trials. Most Phase I studies are conducted in normal healthy volunteers (NHV); NHVs are also used as a cohort of a Phase I study in metabolic, neurologic, psychiatric, endocrine, and cardiac disorders. We have access to a wide range of healthy subject profiles, and, whatever your compound, we stand ready to help you explore its clinical pharmacology.
Demonstrated Expertise in Key Indications
- Human Abuse Liability
- Respiratory Depression
- ETOH interaction
- First-in-Human
- Cardiac Safety, Thorough QT/QTc
- Absolute Bioavailability
- Bioequivalence
- Drug-Drug Interaction
- First-to-File
- Food Effect
- Patch Irritability
- Pharmacokinetic/Pharmacodynamic
- Relative Bioavailability
- SAD/MAD
